Effectiveness and cardiovascular safety of delamanid-containing regimens in adults with multidrug-resistant or extensively drug-resistant tuberculosis: A nationwide cohort study from Belarus, 2016-18
Vera Auchynka(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Alena Skrahina(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Askar Yedilbayev(World Health Organization Regional Office for Europe), Aliaksandr Skrahin(Belarusian State Medical University), Dzmitry Katovich(Klinikum Mittelbaden), Hennadz Hurevich(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Svetlana Setkina(National Board of Examinations), Varvara Solodovnikova(Republican Scientific and Practical Centre of Pulmonology and Tuberculosis), Ajay Kumar(International Union Against Tuberculosis and Lung Disease), Yuliia Sereda(World Health Organization Regional Office for Europe)
Cited by 12
Related Papers
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
|European Respiratory Journal|2019|176
The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis
|Journal of Clinical Microbiology|2017|140
Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
|European Respiratory Journal|2019|130